Continued Administration of G-202 for One Patient With Advanced Hepatocellular Carcinoma
NCT02082691
·
clinicaltrials.gov ↗
NO_LONGER_AVAILABLE
Status
OTHER
Sponsor class
Conditions
Hepatocellular Carcinoma
Interventions
DRUG:
G-202
Sponsor
Devalingam Mahalingam
Collaborators
[object Object]